MEXICO – The first shipment of 200,000 CoronaVac vaccines against COVID-19 arrived in Mexico this Saturday from China, Foreign Minister Marcelo Ebrard confirmed.
“The 200,000 doses of the Sinovac vaccine arrived from Hong Kong,” the official said through his personal Twitter account and explained that, starting today, Pfizer, AstraZeneca and Sinovac vaccines will be applied in Mexico.
Similarly, he reiterated that a total of 10 million doses of this vaccine will arrive in the following weeks.
The undersecretary for Multilateral Affairs of the Ministry of Foreign Affairs, Martha Delgado, headed the protocol for receiving the vaccines at the Mexico City International Airport.
During the formal ceremony, Delgado pointed out that it is the fifth vaccine to receive emergency approval in Mexico and the fourth to arrive in the country, in addition to being the first nation to have two Chinese vaccines.
On Friday night, the Undersecretary of Prevention and Health Promotion, Hugo López-Gatell explained that it is about 200,000 doses that will be used, in packages, for a single territorial demarcation or municipality of the Valley of Mexico with a high rate of marginalization and high mortality from the virus.
They invest in expensive protocols that prevent contagion between students.
He also said that on February 28 800,000 more doses will arrive to have a million of these biologics during February.
He recalled that the Mexican government has bought Sinovac “10 million doses of vaccines that will be used in 5 million people, it is a double dose scheme.”
In addition, he reported that the Russian Sputnik V vaccine will arrive in Mexico on Monday at 11:00 p.m.
Until this Friday, 1 million 574,158 vaccines against COVID-19 have been applied in Mexico but only 418,931 people have received the two doses necessary to achieve immunity.
The country, with 126 million inhabitants, has committed 34.4 million doses of the American Pfizer, 79.4 of the British AstraZeneca, 35 of the Chinese CanSino, 24 of the Russian Sputnik V, 10 of the Chinese Sinovac and 51.4 of the Covax platform of the World Health Organization (WHO).